Estimates of child deaths prevented from malaria prevention scale-up in Africa 2001-2010 by Eisele, Thomas P et al.
RESEARCH Open Access
Estimates of child deaths prevented from malaria
prevention scale-up in Africa 2001-2010
Thomas P Eisele
1*, David A Larsen
1, Neff Walker
2, Richard E Cibulskis
3, Joshua O Yukich
1, Charlotte M Zikusooka
4
and Richard W Steketee
5
Abstract
Background: Funding from external agencies for malaria control in Africa has increased dramatically over the past
decade resulting in substantial increases in population coverage by effective malaria prevention interventions. This
unprecedented effort to scale-up malaria interventions is likely improving child survival and will likely contribute to
meeting Millennium Development Goal (MDG) 4 to reduce the < 5 mortality rate by two thirds between 1990 and
2015.
Methods: The Lives Saved Tool (LiST) model was used to quantify the likely impact that malaria prevention
intervention scale-up has had on malaria mortality over the past decade (2001-2010) across 43 malaria endemic
countries in sub-Saharan African. The likely impact of ITNs and malaria prevention interventions in pregnancy
(intermittent preventive treatment [IPTp] and ITNs used during pregnancy) over this period was assessed.
Results: The LiST model conservatively estimates that malaria prevention intervention scale-up over the past
decade has prevented 842,800 (uncertainty: 562,800-1,364,645) child deaths due to malaria across 43 malaria-
endemic countries in Africa, compared to a baseline of the year 2000. Over the entire decade, this represents an
8.2% decrease in the number of malaria-caused child deaths that would have occurred over this period had
malaria prevention coverage remained unchanged since 2000. The biggest impact occurred in 2010 with a 24.4%
decrease in malaria-caused child deaths compared to what would have happened had malaria prevention
interventions not been scaled-up beyond 2000 coverage levels. ITNs accounted for 99% of the lives saved.
Conclusions: The results suggest that funding for malaria prevention in Africa over the past decade has had a
substantial impact on decreasing child deaths due to malaria. Rapidly achieving and then maintaining universal
coverage of these interventions should be an urgent priority for malaria control programmes in the future.
Successful scale-up in many African countries will likely contribute substantially to meeting MDG 4, as well as
succeed in meeting MDG 6 (Target 1) to halt and reverse malaria incidence by 2015.
Background
Malaria is a major contributor to child mortality in sub-
Saharan Africa [1,2]. Fortunately, vector control through
insecticide-treated mosquito nets (ITNs) and malaria
prevention during pregnancy through ITNs and inter-
mittent prevention therapy (IPTp), have been shown to
significantly reduce the burden of malaria from carefully
conducted trials [3-6]. A recent analysis of 29 national-
level cross-sectional datasets in Africa that assessed the
association between ITN household possession and all-
cause post-neonatal child mortality showed the effect of
ITNs under routine programme conditions to be nearly
identical to, if not greater than, the efficacy observed in
trials [7].
Since the launch of the Roll Back Malaria Partnership
(RBM) in 1998, many countries have worked to expand
coverage of these proven malaria prevention interven-
tions. Funding from external agencies for malaria con-
trol in Africa has increased by a factor of 40 since 2000,
reaching more than US$1.47 billion in 2009 [8,9]. As a
result of both increased funding from external agencies
and increased attention to malaria by national govern-
ments, national coverage levels of malaria prevention
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dramatically across sub-Saharan Africa. This unprece-
dented effort to scale-up malaria interventions is likely
improving child survival and will likely contribute sub-
stantially to meeting Millennium Development Goal
(MDG) 4 (Target 1) to reduce the < 5 mortality rate by
two thirds between 1990 and 2015.
Unfortunately, vital registration data are generally not
available in most malaria-endemic countries for ascer-
taining changes in malaria-specific and all-cause child
mortality [10-13]. Other methods for measuring child
mortality in Africa, such as demographic surveillance
systems and household surveys, have serious limitations
for producing timely trends in malaria mortality at the
country level. Thus, real-time tracking of changes in
child mortality, especially malaria-specific mortality, pre-
sents serious challenges.
Mathematical modelling has been recommended as a
method to gain perspective into the possible impact of
malaria interventions [14]. Previous modelling estimates
have suggested that approximately 691,000 all-cause
child deaths could have been prevented in the year 2000
alone had universal coverage of ITNs been achieved,
and 22,000 child deaths could have been prevented in
2000 had universal coverage of IPTp been achieved [15].
Another cost-effectiveness modelling approach esti-
mated that approximately seven million additional dis-
ability adjusted life-years (DALYs) could be averted by
adding universal ITN coverage on top of universal
access to malaria treatment with artemisinin-based com-
bination therapy (ACT) [16].
To estimate the impact that improved access to effec-
tive child survival interventions have on reducing child
mortality, estimates of the relative reduction in child
mortality of empirically proven child survival interven-
tions have been linked to the population coverage of
such interventions. This effort culminated in estimates
of the impact of scaling-up interventions in The Lancet
S e r i e so nC h i l dS u r v i v a l[ 1 5 ] ,N e o n a t a lS u r v i v a l[ 1 7 ] ,
and Maternal and Child Under-nutrition [18,19]. A cen-
tral component to that work was the development of a
model to estimate the reduction in child mortality that
could be achieved with expanded coverage of effective
child survival interventions. This model, now referred to
as the Lives Saved Tool (LiST), has continued to be
refined to allow retrospective estimation of deaths pre-
vented by intervention scale-up. The use of LiST to ret-
rospective model estimates of neonatal and child deaths
prevented from the scale-up of packages of child survi-
val interventions have been shown to yield reasonably
reliable estimates when compared to measured changes
in mortality across various settings, including neonatal
mortality in South Asia [20], all-cause < 5 year child
mortality from a broad package of child health
interventions in West Africa [21], and all-cause < 5 year
child mortality in Bangladesh [22].
It is known that the coverage of malaria prevention
interventions, especially vector control through ITNs,
has increased dramatically over the past 10 years in
Africa, with the bulk occurring since 2005. However, it
remains unknown what impact this increased access to
proven malaria prevention intervention has had on child
mortality over the past decade. The LiST model was
used to approximate the likely impact that malaria pre-
vention intervention scale-up has had on child malaria
mortality over the past decade (2001-2010) across 43
malaria-endemic countries in Africa. Estimates of the
cost effectiveness of ITNs are estimated from 2006-2009
during the peak scale-up. The model was also used to
estimate the potential number of malaria deaths that
could be prevented from additional scale-up of malaria
prevention interventions to the RBM universal coverage
target of 100% from 2012 through 2015 [23]. Unfortu-
nately, due to difficulties with the definition and match-
ing coverage estimates of prompt treatment of
childhood fevers with ACT to estimates of the efficacy
of ACT at preventing child deaths [24], the current ana-
l y s i sd o e sn o ti n c l u d ea ne s t imate of the child deaths
prevented from malaria treatment.
Methods
This analysis, using the LiST model, focused on estimat-
ing the impact of ITNs for preventing post-neonatal
(one-59 months of age) child malaria deaths from 2001-
2010, as compared to a baseline of 2000. A baseline of
2000 was chosen as this is the year prior to any scale-up
of ITNs or malaria prevention in pregnancy interven-
tions in most African countries. Forty-three countries in
sub-Saharan Africa are included in this analysis; 43 for
the ITN analysis and 32 for the malaria prevention in
pregnancy analysis (Figure 1) [25].
This analysis of malaria prevention during pregnancy
(with either IPTp or ITNs) for preventing all-cause < 5
child deaths through prevention of low birth-weight
(LBW) was limited to 32 countries in Africa with stable
malaria transmission. These countries accounted for
88% of the population in SSA at risk of malaria and 90%
of the malaria-caused child deaths in 2000 in SSA
[25,26]. A list of excluded countries from the analyses,
as well as the rationale for exclusion, can be found in
Additional file 1.
The LiST model is based on the earlier work on effec-
tiveness of interventions developed by WHO and UNI-
CEF’s Child Health Epidemiology Reference Group
(CHERG) and RBM’s Monitoring and Evaluation Refer-
ence Group (MERG). The model starts with estimates
and assumptions within each country on the profiles for
population and population growth, under-five cause of
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rent coverage estimates of key child survival interven-
tions [27]. The model used in this analysis and
accompanying documentation can be downloaded [28].
The model estimates child deaths prevented (within
specific cause of death categories) due to intervention
scale-up within a specified country as a function of
three primary parameters, as outlined in details below:
1) the number of child deaths by cause projected to
occur in each year (including population growth para-
meters over time); 2) the protective effect (PE) on
cause-specific mortality (PE = 1-relative risk*100) for
each intervention being scaled-up; and 3) increases in
population coverage of each intervention. The model
computes the number of deaths prevented by cause
each year, accounting for population growth, as the dif-
ference between the estimated deaths that occur with
intervention scale-up and the estimated deaths that
would have occurred without intervention scale-up
beyond the coverage at a baseline year. Further details
of the LiST model estimation methods are presented in
the Additional file 1.
Parameter 1- within country estimates of cause-specific
child deaths
Within the LiST model, the total number of < 5 child
deaths for the baseline year of 2000, by age, is based on
estimates of < 5 mortality produced by the UN Inter-
agency Group for Child Mortality Estimation (IGME)
[29]. The number of post-neonatal child malaria deaths
in our baseline year of 2000 was estimated as the pro-
portion of child deaths one-59 months attributable to
malaria [26], multiplied by the total number of all-cause
< 5 child deaths one-59 months in the year 2000. Based
on this method, the LiST model started with 870,928
malaria-caused deaths one-59 months in 43 African
countries and 1,034,828 all-cause neonatal deaths in 32
African countries in the baseline year of 2000 (Addi-
tional file 2).
Parameter 2- estimates of intervention effectiveness
As described in detail elsewhere, the PE of ITNs for pre-
venting post-neonatal child malaria deaths has been esti-
mated to be 55% (range 49-60%) based on a systematic
review and meta-analysis of three trials [30].
Malaria in pregnancy increases the risk of LBW,
resulting primarily from intrauterine growth retarda-
tion (IUGR) in areas of stable P. falciparum malaria
transmission [31], while LBW has been demonstrated
to be a significant risk factors for neonatal and infant
mortality [32-34]. The PE of malaria prevention during
pregnancy for preventing LBW has been estimated to
be 35% (95% confidence interval [CI] 23-45%) during
the first two pregnancies in malaria endemic areas
based on a systematic review of 2 ITN trials and 3
IPTp trials conducted in 1998 and 2002 in Kenya and
2004 in Mozambique, after the onset of sulphadoxine-
pyrimethamine (SP) resistance [30]. The effect of
malaria prevention interventions during pregnancy on
LBW in the LiST model acts solely through intrauter-
ine growth retardation (IUGR). IUGR in the LiST
model acts mostly through neonatal mortality, increas-
ing the risk of dying during this period due to diar-
rhoea [RR = 2.0], sepsis/pneumonia (RR = 2.0), and
asphyxia (RR = 2.3). During the post-neonatal period,
IUGR slightly increases the risk of dying due to
measles, malaria, diarrhoea and pneumonia [18,35], via
links between IUGR and stunting. In this analysis, the
effect of IPTp and ITNs acted only on child deaths
from the first two pregnancies of women in each
country.
Parameter 3- changes in coverage of malaria prevention
interventions
Estimates of household ITN coverage used in this analy-
sis were based upon previous publications that modeled
the proportion of household with ≥ 1 ITN each year in
each country in Africa based on survey data and ITN
procurement and distribution data, with uncertainty
[35,36]. These estimates are adjusted for each country’s
population at-risk for malaria such that coverage reflects
Figure 1 Malaria-endemic countries included in estimates of
malaria intervention scale-up and resultant malaria-caused
child deaths prevented 2001-2010.
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households in malaria endemic areas of the country.
The LiST model uses ITN household possession
instead of ITN use by children because the trials from
which 55% PE was derived all used intention-to-treat
analyses, meaning the estimated effects (relative risk)
were based on whether or not a child lived in a village
that had high ITNs household possession. Results from
the analysis of the association between ITNs and all-
cause post-neonatal mortality across 29 cross-sectional
datasets in Africa showed very little difference in the
effect regardless of whether ITN household possession
or ITN use by children the previous night was used [7],
further supporting the use of household ITN possession
instead of child use.
The impact of malaria prevention during pregnancy
on LBW and subsequent < 5 child survival was esti-
mated using the higher of the following two coverage
indicators: 1) proportion of pregnant women using an
ITN the previous night or; 2) the proportion of women
who had a live birth in the past two years who
received ≥ 2 doses of SP during an ante-natal care
(ANC) visit. The authors are unaware of published
yearly national estimates of malaria protection during
pregnancy. Estimates of coverage of malaria prevention
during pregnancy used in this analysis were derived
from nationally representative household surveys,
including the Demographic and Health Survey (DHS),
the Multiple Indicator Cluster Survey (MICS), the
Malaria Indicator Survey (MIS) and the AIDS Indicator
Survey (AIS), as summarized below and described in
detail elsewhere (Additional file 1). Because the major-
ity of malaria deaths and the burden of malaria in
pregnancy is concentrated in rural areas [1,37], and as
intervention coverage in rural areas has often lagged
behind urban areas in many countries in Africa [38],
the level of malaria prevention during pregnancy in
rural areas was used for estimating the malaria deaths
prevented from malaria prevention during pregnancy
scale-up at the national level.
If there was no survey data point for IPTp/ITN cover-
age in 2000, coverage was assumed to be 0%. Linear
interpolation was used from the first year of measured
IPTp/ITN coverage, or from 0% coverage in 2000, to
the next available survey point estimate. This slope was
then used to inform the increase for years beyond the
most recent household survey through 2010. In the case
that there was only one household survey in the coun-
try, coverage was assumed to be 0% in the year IPTp
was implemented as policy, and a linear slope was calcu-
lated from that year to the household survey data point.
For countries projected to reach ≥ 80% coverage, maxi-
mum coverage estimates were limited to the proportion
of women attending ANC at least once in last nationally
representative household survey (see Additional file 1
for details on methods, as well as Additional files 3 and
4 for results).
Key assumptions of this LiST analysis
The LiST model analysis conducted here has several
important assumptions. First, the LiST model assumes
that the PE of interventions is constant across each
country in this analysis. While the PE of ITNs interven-
tions varies across level of intervention coverage in the
population, child age and malaria transmission level, the
PE of ITNs used in this analysis is assumed to represent
a valid estimate of the mean effect across these effect
modifiers. Results from an analysis of 29 cross-sectional
country datasets in Africa since 2000 with varying levels
of ITN coverage and across varying levels of malaria
transmission showed the average effectiveness of ITN
under programme conditions to be very similar to the
trials for reducing all-cause one-59 month child mortal-
ity, which helps support the use of a fixed 55% PE for
ITNs used here [39]. A previous validation study of the
LiST model against measured reductions in all-cause
child mortality following the scale-up of ITNs, across a
range of transmission settings, further validates the use
of the fixed PE of 55% for ITNs used here [40]. Second,
while there is evidence that malaria acts as a significant
risk factor for dying from conditions other than malaria
during childhood [41], the LiST model constrains deaths
prevented by malaria control within the envelope of
malaria-attributable < 5 deaths. Deaths associated indir-
ectly with malaria as a contributory cause were not
counted, although the ITN trials had shown that this
indirect contribution of malaria may be an equally
important additional contribution of malaria’so v e r a l l
effect on < 5 mortality as the directly malaria-attributed
deaths.. Third, intervention coverage for a given year is
assumed to be a valid estimate for the mean coverage
over the 12-month period. Fourth, due to a lack of data
to quantify effect modification, the model does not
account for any possible synergistic or saturation effect
between ITNs and IPTp for preventing child deaths
[42]. And lastly, coverage by a malaria prevention inter-
vention is assumed independent from coverage by
another malaria prevention intervention, which is likely
not true.
Calculation of percent reduction in malaria deaths
Percent reduction in malaria deaths were estimated by
dividing the number of malaria deaths estimated to
occur with intervention coverage scale-up in a given
year (or over a period of years) by the number of
malaria deaths estimated to have occurred in that year
(or over that period) had no intervention scale-up
occurred from 2000.
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Uncertainty bounds about total estimated post-neonatal
child malaria deaths prevented from ITNs 2001-2010
were based on a non-probabilistic sensitivity analysis of
the uncertainty of the three primary model parameters.
This resulted in a worst-case (i.e. low-impact) and best-
case (i.e. high-impact) scenario, with the worst-case using
the lower bound of estimated post-neonatal malaria
deaths in 2000 in each country [26], the lower bound of
the PE for ITNs (49%) [30], and the smallest net increase
(slope) in ITNs scale-up 2001-2010 for each country
based on the uncertainty of the coverage estimates by
Flaxman and colleagues [35]. The best-case scenario
resulted from using the upper bound of estimated post-
neonatal malaria deaths in 2000 in each country, the
upper bound of the PE for ITNs (60%), and the largest
net increase (slope) in ITNs scale-up 2001-2010 for each
country based on uncertainty about the coverage esti-
mates (Additional file 1 for details on methods).
Uncertainty bounds about total estimated < 5 deaths
prevented from malaria prevention during pregnancy
2001-2010 were obtained based on a similar non-prob-
abilistic sensitivity analysis of the uncertainty of two pri-
mary model parameters: lower and upper bound of the
estimated PE of malaria prevention in pregnancy on pre-
venting LBW [30], and the smallest and largest net
increases in intervention coverage changes within each
country from 2001-2010 based on sampling errors (see
Additional file 1 for details on methods, as well as Addi-
tional file 4 for resultant uncertainty of malaria preven-
tion in pregnancy scale-up for each country 2000-2010).
This resulted in a worst-case and best-case scenario as
described above.
Cost effectiveness
A review of existing literature on the costs and cost effec-
tiveness of ITN delivery [ITN or long-lasting ITN (LLIN)]
in Africa since 2005 was conducted in PubMed and the
grey literature; 13 studies were identified and included
[43-55]. Costs of ITN programmes were separated into
delivery and commodity components, and used to esti-
mate a median cost of ITN delivery, and of ITNs procured
for programmes. Total costs were then calculated over the
period 2006-2009 following previous methodological
guidelines [56,57]. Costs were combined with estimates of
lives saved and Disability Adjusted Life Years (DALYs)
over this time period to produce cost effectiveness results.
A one-way sensitivity analysis was also conducted (see
Additional file 1 and 5 for additional details).
Results
The 2001-2010 decade
Using the LiST model, this analysis estimated that
malaria prevention intervention scale-up over the past
decade has prevented 842,800 (uncertainty: 562,800-
1,364,600) malaria-caused child deaths across 43
malaria-endemic countries in Africa, compared to a
baseline of the year 2000 (Figure 2). Over the entire
decade, this represents an 8.2% decrease in the number
of malaria-caused child deaths that would have occurred
over this period had malaria prevention coverage
remained unchanged since 2000 coverage levels. The
biggest impact occurred in 2010 with a 24.4% decrease
in malaria-caused child deaths compared to what would
have happened had malaria prevention interventions not
been scaled-up beyond 2000 coverage levels.
Based on the estimated coverage of household posses-
sion of ≥ 1 ITN [36,37], it is estimated that scale-up of
ITNs prevented 831,100 (uncertainty: 555,800-1,347,200)
post-neonatal child malaria deaths across the 43 coun-
tries included in this analysis from 2001 through 2010
(Additional file 2). In Nigeria alone, which had an ITN
coverage increase from 0 to 45% over this period,
165,700 (uncertainty: 96,800-240,000) post-neonatal
child malaria deaths were estimated to have been pre-
vented. Other main contributors to the total post-neo-
natal child malaria deaths prevented over the past
decade, due primarily to substantial ITN scale-up and
their large population size, include the Democratic
Republic of the Congo, Ethiopia, Mali, Tanzania and
Uganda, which total 286,300 (uncertainty: 205,000-
429,800) child malaria deaths prevented compared to
2000.
From ITN coverage scale-up 2001-2010, Namibia was
estimated to have the largest percentage decline in post-
neonatal malaria deaths from 2001-2010 with a 26%
decline, while accounting for population growth, fol-
lowed by Eritrea (24% decline), Togo (21% decline),
Mali (21%) and Djibouti (19%) (Figure 3). The five Afri-
can countries analysed with the largest number of
malaria deaths in 2000 had the following percentage
declines in post-neonatal malaria deaths from 2001-
Figure 2 Number of yearly malaria-caused child deaths
prevented by malaria prevention interventions scale-up 2001-
2010.
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Congo (DRC) (9% decline), Uganda (14% decline), Tan-
zania (3% decline) and Southern Sudan (6% decline).
For many countries, the bulk of the decline in malaria-
caused mortality occurred in 2010 following rapid ITN
scale-up (Figure 3 and Additional file 2 Table 1). Dji-
bouti was estimated to have the largest percentage
decline in post-neonatal malaria deaths in 2010 with a
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compared to malaria deaths in
2010 with no ITN scale-up
Percent reduction in one-59 month malaria-caused deaths 
Figure 3 Percent reduction in malaria-cased child deaths one-59 months.
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babwe (29% decline), Togo (26% decline), Madagascar
(26% decline), Mali (21%), Senegal (21% decline) and
Gabon (21% decline).
Across the 32 countries with stable malaria transmis-
sion included in this analysis, it is estimated the propor-
tion of pregnant women protected by either IPTp or
ITNs in rural areas increased from a mean of 0.7% in
the year 2000 to 41.8% in 2010 (Figure 4). It is estimated
that from 2001-2010 IPTp and ITNs used during preg-
nancy prevented a total of 11,700 (uncertainty: 7,000-
17,500) child deaths from LBW as a result of malaria in
pregnancy, as compared to a baseline year of 2000
(Additional file 2).
Cost effectiveness 2006-2009
This analysis estimated the median cost of delivery of an
ITN to be US$1.64 (Table 1 in Additional file 5). There
was some difference between subgroups of delivery sys-
tems (median US$1.34 for mass campaigns and US$3.96
for retail distribution). This analysis estimated the med-
ian procurement cost of an ITN to be US$5.44. When
discounted over a three-year period, one year of ITN
ownership was valued at US$1.85. The number of ITNs
available in each year in all of the relevant areas of sub-
Saharan Africa was estimated to be approximately 130
million, yielding approximately 520 million available net
years over the period 2006-2009. Large differences in
availability of nets arose from different assumptions of
net lifetimes although this did not result in large differ-
ences in cost-effectiveness estimates (See Table 2 in
Additional file 5). The total discounted cost of all ITNs
and their delivery was estimated to be approximately US
$1.3 billion. Based on predictions from the LiST model,
the number of discounted lives saved using vector con-
trol methods over the period (2006-2009) was 475,800,
resulting in an estimated US$2,770 per life saved. Lives
saved over this period translate into approximate 11.9
million DALYs, resulting in an estimated US$111 per
DALY averted. Results were particularly sensitive to var-
iation in the price of an ITN and the number of nets
delivered, but the intervention remained very attractive
in low-income country settings under all scenarios
tested (for the full results of the sensitivity analysis see
Additional file 5).
Estimates for 2011-2015
Five possible ITNs scale-up scenarios beyond 2010 were
examined (Figure 5). In the case of rapid scale up from
estimated 2011 coverage levels to universal coverage
(100%) by the end of 2012 and maintained through
2013-2015, it is estimated that 2.77 million post-neona-
tal child deaths could be prevented for this five-year
interval. Achieving such universal coverage of ITNs
would result in a 54% reduction in malaria-caused child
mortality compared to maintaining 2000 coverage levels,
after accounting for population growth; this translates to
a decline in the 2015 all-cause < 5 mortality rate by
11.2% due solely to ITNs. With linear scale-up to uni-
versal coverage by the end of 2015 from 2011 levels, it
is estimated 2.28 million child deaths could be pre-
vented for this five-year interval, as compared to
Year 
Figure 4 Proportion of pregnant women in rural areas
protected by malaria prevention interventions (IPTp and/or
ITNs) across 32 countries in sub-Saharan Africa 2000-2010.
Figure 5 Number of yearly post-neonatal child malaria deaths
prevented by ITNs, according to different scale-up scenarios
2011-2015. Continuing current trend was calculated using the
slope between the most recent survey estimate and the earliest
survey estimate (solid blue line). Achieving 100% coverage by 2015
assumes linear ITN coverage increases to 100% from estimated
coverage in 2010 (dotted purple line). Maintaining coverage
assumes estimated coverage in 2010 continues through 2015
(dashed orange line). Ceased funding was calculated assuming that
ITNs last three years and have a net discard rate of 4% each year
[36] (dashed red line).
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scale-up trends 2000-2011 are continued on the same
slope through 2012-2015, it is estimated that an addi-
tional 1.71 million child deaths could be prevented from
2011-2015, as compared to 2000 coverage levels. Alter-
natively, if current country coverage is stabilized at 2011
levels, it is estimated that 1.45 million child deaths
could be prevented. However, if funding ceased and vec-
tor control strategies were no longer available and long-
lasting ITN (LLIN) coverage decreased over the five-
year interval, assuming LLINs last about three years
[59], as many as 640,400 children would die as a result
during this period, compared to maintaining 2011 cov-
erage until 2015.
Discussion
This analysis used the LiST model to estimate the effect
of malaria prevention scale-up over the past decade on
reductions in malaria-caused child mortality across 43
malaria-endemic countries in A f r i c a .T h i sa n a l y s i se s t i -
mates that from 2001 through 2010, scale-up of malaria
interventions likely prevented nearly one million
(842,800) child deaths across these countries, corre-
sponding with a mean decrease in malaria-caused deaths
by 8.2% over the entire period. This represents saving
230 children from dying from malaria each day over the
past decade as a result of malaria prevention scale-up,
increasing from seven children saved each day in 2001
up to 741 saved each day in 2010.
Compared to a baseline of 2000 in the 43 countries
analysed here, it is estimated that malaria-caused deaths
in children one-59 months decreased by 24.4%, after
accounting for population growth. While our estimates
suggest that no country achieved the RBM goal of a
50% reduction in malaria deaths in 2010 compared to
2000, after accounting for population growth, it is esti-
mated that 8 countries achieved ≥ 20% reduction from
2001-2010: Djibouti, Namibia, Zimbabwe, Madagascar,
Togo, Senegal, Mali, and Gabon.
In this analysis, the majority of the child deaths pre-
vented occurred since 2006 once scale-up of ITNs accel-
erated across the continent. ITNs accounted for 99% of
the estimated child deaths prevented in this analysis,
which did not include case management with ACT or
IRS. Nearly 2.27 million child deaths could be prevented
from 2011-2015 if universal coverage (100% of house-
holds) with ITNs is achieved by 2015, resulting in halv-
ing (54%) child malaria deaths compared to 2000
coverage levels after accounting for population growth.
However, if funding ceased and the population coverage
level of vector control strategies waned, nearly more
than a half million children would die as a result.
Rapidly achieving and then maintaining universal cover-
a g eo fI T N ss h o u l db ea nu r g e n tp r i o r i t yf o rm a l a r i a
control programmes. Millions of child deaths can be
prevented.
Though the estimated cost per DALY averted (US
$111) and life saved (US$2,770) using ITNs are slightly
higher than in some recent studies [46,48,58], they still
fall into a range feasible for low-income countries.
These estimates of cost are based on deliveries of nets
on a continental scale, and thus incorporate programme
leakage, wastage, delayed delivery to households, and
targeting of populations other than children and preg-
nant women, making them conservative as compared to
those derived directly from trials. Despite this conserva-
tive approach, the intervention meets the criteria for
being very cost-effective in a less developed country
established by the WHO Commission on Macroeco-
nomics and Health; one DALY averted for less than
average per capita income (for the countries included in
this analysis the median GNI per capita was USD 590 in
2009 (Inter Quartile Range (USD 410-1,215) [59]. The
scale-up of ITNs for malaria in sub-Saharan Africa has
clearly been a sound investment in health.
There are number of important limitations to this
analysis that must be considered when interpreting
these results. First, other than the input parameter for
child mortality for each country in 2000 that is based on
IGME estimates, which are based on an analysis of all
available mortality data for the given country [29], child
mortality was never directly measured using this model-
ling approach. Second, this analysis is based on a num-
ber of key assumptions as outlined in the Methods
section. If any of these are wrong, these results are likely
biased accordingly. However, every effort was made to
be as conservative as possible in making the assump-
tions, which would likely translate to an underestimation
of the true number of malaria deaths prevented from
malaria prevention interventions over the past decade.
Third, projecting the proportion and number of deaths
due to malaria from a baseline year to subsequent years
using the LiST model, for both the counterfactual and
intervention scale-up, does not account for unmeasured
influences that may affect malaria mortality in subse-
quent years, such as changes in environmental condi-
tions, insecticide resistance, urbanization, overall
development or political stability. Fourth, it is highly
likely the PE of vector control is heterogeneous across
gradients of malaria transmission, by type of vector,
child age, and age and integrity of the ITN. However,
due to a paucity of available data, it is not currently pos-
sible to vary the PE of ITNs by potential effect-modify-
ing variables. However, there is an on-going attempt to
refine the PE of ITNs interventions in LiST to be sensi-
tive to these effect modifiers, including a community
effect at high coverage levels. It is hoped future esti-
mates will be refined accordingly. Fifth, the PE of IPTp
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spread SP resistance; the PE of IPTp with SP may have
diminished in the latter years of the past decade and are
not accounted for in this analysis. Sixth, modelling case
management of malaria with prompt effective treatment
with ACT is currently not possible in LiST, primarily
due to a lack of data that can be matched between cov-
erage indicators and the PE of ACT [24]. Inclusion of
ACT in future modelling efforts would likely increase
the number of child deaths prevented.
As previously mentioned, two studies lend credibility
to the LIST model’s ability to retrospectively estimate
the effect of ITNs preventing child malaria deaths. First,
the LiST model did reasonably well compared to esti-
mates of measured reductions in < 5 mortality following
the scale-up of ITNs in 4 studies across a range of
transmission setting [40]. Second the effectiveness of
household ownership of ≥ 1 ITN at preventing all-cause
post-neonatal mortality under routine malaria program
settings was recently found to have nearly the identical
effectiveness as that seen in the ITNs trials, upon which
the LiST model ITN PE is based [7].
The estimated prevention of malaria child deaths over
the past decade may appear to show only a moderate
impact on child mortality. In fact these projections are
very conservative. First, this analysis did not include the
deaths prevented from prompt treatment of fevers with
ACT. By 2008, all but one malaria-endemic country in
Africa had adopted ACT as the first-line drug for
uncomplicated Plasmodium falciparum malaria [9]. This
increased access to effective anti-malarials is very likely
to have prevented an additional number of malaria
deaths over the past decade. However insufficient data
on testing and treatment precluded this from being part
of these analyses. Second, this analysis does not account
for the likely benefit of ITN scale-up on indirect malaria
mortality where malaria is prevented as a co-infection
that contributes to a child death [41]. Third, the effect
of malaria prevention in pregnancy acts solely through
IUGR in LiST and not specifically through prematurity,
which would likely have a larger impact on neonatal
mortality [30]. Fourth, ITN coverage of pregnant
women was estimated by ITN use by pregnant women
the previous night to be most conservative, which likely
provides an underestimation of the true protection con-
ferred to women as a result of the community effect
from vector control interventions. Fifth, this analysis
defaulted to the most conservative estimates of yearly
intervention coverage changes where interpolations were
made between survey estimates. Finally, IRS, which is
estimated to have an effect on malaria-caused mortality
similar to that of ITNs, was not included in this analysis
because of the paucity of national level coverage esti-
mates 2001-2010.
These modelling results suggest that funding for
malaria prevention in Africa over the past decade has
had a substantial effect on decreasing child malaria
deaths. Declines in child malaria deaths as a result of
achieving universal coverage of malaria prevention inter-
ventions, especially in combination with improved
access to diagnosis and effective case management, will
likely contribute substantially to meeting MDG 4, to
r e d u c et h e<5m o r t a l i t yr a t eb yt w ot h i r d sb y2 0 1 5 .
Moreover, most African countries will be able to meet
the MDG 6 (Target 3) of halting and reversing trends in
malaria incidence with successful scale-up of malaria
control interventions. However, it has been estimated
that a substantial funding gap remains to achieve full
malaria control scale-up in Africa; international donors
must do more to allow countries to achieve and main-
tain universal coverage as rapidly as possible [36,60,61].
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